A detailed history of Dodge & Cox transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Dodge & Cox holds 17,073,791 shares of ZBH stock, worth $1.87 Billion. This represents 1.12% of its overall portfolio holdings.

Number of Shares
17,073,791
Previous 16,745,630 1.96%
Holding current value
$1.87 Billion
Previous $1.82 Billion 1.41%
% of portfolio
1.12%
Previous 1.15%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$104.47 - $116.17 $34.3 Million - $38.1 Million
328,161 Added 1.96%
17,073,791 $1.84 Billion
Q2 2024

Aug 13, 2024

BUY
$106.25 - $130.01 $34.7 Million - $42.4 Million
326,360 Added 1.99%
16,745,630 $1.82 Billion
Q1 2024

May 14, 2024

BUY
$119.98 - $132.61 $593 Million - $656 Million
4,944,735 Added 43.09%
16,419,270 $2.17 Billion
Q4 2023

Feb 15, 2024

BUY
$102.72 - $121.7 $683 Million - $809 Million
6,647,810 Added 137.73%
11,474,535 $1.4 Billion
Q3 2023

Nov 14, 2023

SELL
$110.76 - $143.18 $4.18 Million - $5.41 Million
-37,775 Reduced 0.78%
4,826,725 $542 Million
Q2 2023

Aug 14, 2023

SELL
$126.43 - $145.6 $7.24 Million - $8.34 Million
-57,250 Reduced 1.16%
4,864,500 $708 Million
Q1 2023

May 12, 2023

SELL
$121.91 - $130.94 $3.13 Million - $3.37 Million
-25,700 Reduced 0.52%
4,921,750 $636 Million
Q4 2022

Feb 14, 2023

SELL
$104.7 - $128.4 $42.6 Million - $52.3 Million
-407,050 Reduced 7.6%
4,947,450 $631 Million
Q3 2022

Nov 10, 2022

SELL
$101.65 - $119.27 $5.7 Million - $6.69 Million
-56,100 Reduced 1.04%
5,354,500 $560 Million
Q2 2022

Aug 12, 2022

BUY
$102.23 - $133.85 $315 Million - $412 Million
3,077,685 Added 131.92%
5,410,600 $568 Million
Q1 2022

May 13, 2022

BUY
$108.42 - $129.58 $253 Million - $302 Million
2,332,915 New
2,332,915 $298 Million

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $22.9B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Dodge & Cox Portfolio

Follow Dodge & Cox and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dodge & Cox, based on Form 13F filings with the SEC.

News

Stay updated on Dodge & Cox with notifications on news.